BPCE
PACB icon

Bank Pictet & Cie (Europe)’s Pacific Biosciences PACB Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26,789
Closed -$244K – 173
2022
Q1 		$244K Buy
26,789
+2,396
+10% +$27.6K 0.01% 154
2021
Q4 		$499K Buy
24,393
+9,052
+59% +$218K 0.02% 131
2021
Q3 		$392K Buy
15,341
+2,201
+17% +$65.2K 0.01% 140
2021
Q2 		$460K Buy
13,140
+1,908
+17% +$55.5K 0.02% 140
2021
Q1 		$374K Buy
+11,232
New +$393K 0.02% 137

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s PACB Position: Q2 2022 in Review

Bank Pictet & Cie (Europe) sold out of Pacific Biosciences (PACB) in Q2 2022, closing a stake of 26,789 shares — an estimated $244K sold.

Bank Pictet & Cie (Europe) first reported a position in PACB in Q1 2021 and held it in 5 quarters. The position peaked at $499K in Q4 2021. 229 funds tracked by Wall St. Rank hold PACB as of Q2 2022.

  • Bank Pictet & Cie (Europe) reported no remaining Pacific Biosciences position as of Q2 2022 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 26,789 Pacific Biosciences shares in Q2 2022, an estimated $244K.
  • Bank Pictet & Cie (Europe) first reported a position in Pacific Biosciences in Q1 2021 and held it in 5 quarters.
  • Bank Pictet & Cie (Europe)'s Pacific Biosciences position peaked at $499K in Q4 2021.
  • 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2022.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2022, filed 5 Aug 2022.